The spectrum of scleroderma (II).
LeRoy
E C
EC
Division of Rheumatology and Immunology, Medical University of South Carolina College of Medicine, Charleston.
Lomeo
R
R
D001992:Bronchoalveolar Lavage Fluid / Q000032:analysis; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D005767:Gastrointestinal Diseases / Q000209:etiology / Q000503:physiopathology; D005769:Gastrointestinal Motility / Q000502:physiology; D006331:Heart Diseases / Q000000981:diagnostic imaging / Q000209:etiology; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000209:etiology; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011658:Pulmonary Fibrosis / Q000175:diagnosis / Q000209:etiology / Q000473:pathology; D011877:Radionuclide Imaging; D011928:Raynaud Disease / Q000150:complications; D012595:Scleroderma, Systemic / Q000150:complications* / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D014652:Vascular Diseases / Q000188:drug therapy / Q000209:etiology
D002121:Calcium Channel Blockers